Seraxis

Seraxis

Developing a cell therapy to treat insulin dependent diabetes. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€182m (Public information from Sep 2023)
Germantown Maryland (HQ)
Authorizing premium user...